Libiguin A

Libiguin A
Clinical data
Drug classPro-sexual agent
ATC code
  • None
Chemical and physical data
FormulaC37H46O13
Molar mass698.762 g·mol−1
3D model (JSmol)
  • C[C@]1(C(C2=COC=C2)=O)[C@@]([C@@]34[C@H](O5)[C@]([C@@H](OC(C(C)C)=O)[C@@]6(C)[C@@H]7CC(OC)=O)(OC(C(C)C)=O)[C@@](C6)(OC(O4)(C)O8)[C@]7(C)[C@@]38CC1)([H])CC5=O
  • InChI=InChI=1S/C37H46O13/c1-18(2)26(41)46-28-31(6)17-35-32(7,21(31)14-23(38)43-9)34-12-11-30(5,25(40)20-10-13-44-16-20)22-15-24(39)45-29(37(28,35)47-27(42)19(3)4)36(22,34)50-33(8,48-34)49-35/h10,13,16,18-19,21-22,28-29H,11-12,14-15,17H2,1-9H3/t21-,22+,28-,29-,30+,31+,32-,33?,34-,35-,36+,37-/m0/s1
  • Key:BFLOIRXWKQQOAJ-PCOGLSORSA-N

Libiguin A is a naturally occurring limonoid found in Neobeguea mahafalensis, a flowering plant found in Madagascar with a long history of traditional medical use.[1][2][3][4][5] It is a derivative of phragmalin.[1] The compound has been reported to produce highly potent, strong, and long-lasting pro-sexual effects in rodents.[1][5] The semisynthesis of libiguin A from phragmalin has been described.[2] An analogue also found in Neobeguea mahafalensis, libiguin B, has similar pro-sexual effects but is far less potent in comparison.[1][2][5] Another analogue, a synthetic compound known as volufralin (LIB-01; DIC-2024), is under development for the treatment of erectile dysfunction and premature ejaculation.[6][7] Libiguin A was first described in the scientific literature by 2014.[1][2]

See also

References

  1. ^ a b c d e Razafimahefa S, Mutulis F, Mutule I, Liepinsh E, Dambrova M, Cirule H, et al. (March 2014). "Libiguins A and B: novel phragmalin limonoids isolated from Neobeguea mahafalensis causing profound enhancement of sexual activity". Planta Medica. 80 (4): 306–314. doi:10.1055/s-0033-1360390. PMID 24549927.
  2. ^ a b c d Grigorjeva L, Liepinsh E, Razafimahefa S, Yahorau A, Yahorava S, Rasoanaivo P, et al. (May 2014). "Semisynthesis of libiguin A and its analogues by trans-lactonization of phragmalin". The Journal of Organic Chemistry. 79 (9): 4148–4153. doi:10.1021/jo500318w. PMID 24716657.
  3. ^ Fossen T, Yahorau A, Yahorava S, Raharinjato F, Razafimahefa S, Rasoanaivo P, et al. (July 2016). "New Polyfunctional Phragmalin Limonoids from Neobeguea mahafalensis". Planta Medica. 82 (11–12): 1087–1095. doi:10.1055/s-0042-108741. PMID 27340794.
  4. ^ Zhang Y, Xu H (2017). "Recent progress in the chemistry and biology of limonoids". RSC Advances. 7 (56): 35191–35220. doi:10.1039/c7ra04715k. ISSN 2046-2069. 3.1.14. Neobeguea. As described in Fig. 15, 11 new limonoids, namely, dodoguin 313, dormir A–G 314–320, 108 libiguins A 321, libiguins B (a) 322 and libiguins B (b) 323, 109 were isolated from the root barks of Neobeguea mahafalensis, a medicinal plant in Madagascar. Interestingly, compounds 318, and 321–323 contained a C-16/30 d-lactone ring, which was the rst time reported in this species. [...] compound 322 exhibited a potent sexual enhancing activity.
  5. ^ a b c Hill RA, Connolly JD (December 2018). "Triterpenoids". Natural Product Reports. 35 (12): 1294–1329. doi:10.1039/c8np00029h. PMID 29993074. Neobeguea mahafalensis is the source of the phragmalin derivatives libiguin A 560 and libiguin B 561 (in equilibrium with its keto tautomer).202 These compounds are reported to have aphrodisiac properties.
  6. ^ "LIB 01". AdisInsight. 26 December 2025. Retrieved 27 January 2026.
  7. ^ Foster B (12 January 2026). "A new approach could radically change erectile dysfunction treatment". Drug Discovery News. Retrieved 27 January 2026.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.